• Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
  • Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
05
Nov

AI identifies Parkinson’s from breathing patterns

AI, Artificial Intelligence, Healthcare Excellence
A new artificial intelligence (AI) model from researchers at MIT can detect Parkinson’s disease, a notoriously difficult disease to detect, through breathing patterns. The tool could help alleviate the disease onset gap between when symptoms of Parkinson’s first appear and when most people receive a diagnosis. The MIT team that developed the AI model uses a neural network to analyse breathing patterns that occur during sleep.
PrevNext

Related Posts

March 28, 2023

5 key trends in PACS and enterprise imaging from Signify Research

increaseoNews0
March 23, 2023

FDA clears new AI-powered cardiac imaging solution

increaseoNews0
March 16, 2023

Cardiac imagers need to understand AI as it enters clinical use and ACC guidelines

increaseoNews0

Latest News

  • 5 key trends in PACS and enterprise imaging from Signify Research
  • Advanced PET/MRI protocols boost lung cancer detection
  • FDA clears new AI-powered cardiac imaging solution

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.

RSS Health Pulse

  • What causes hiccups and how can you get rid of them?
  • TGA review strengthens case for much tighter vape restrictions at the border
  • Bendy joints, stretchy skin, clumsiness. Why hypermobile Ehlers-Danlos Syndrome is often missed – and what it has to do with autism

Twitter

  • PET/MRI achieves similar or superior results to PET/CT for the detection of pulmonary malignancies, according to ne… https://t.co/xreCTlkiok 2 days ago
  • DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. FDA clearance for LVivo IQS, a… https://t.co/14Y4F4TGMP 4 days ago
  • Contrast-enhanced spectral mammography (CESM) is a cost-effective alternative to MRI for patients with breast cance… https://t.co/si86G15I7i 6 days ago
© GCG Global Healthcare Pty Ltd, All rights reserved. ABN 25 136 716 991

Find your next opportunity with
GCG Global Healthcare TODAY!

DISCOVER OUR OPEN POSITIONS NOW!